Genetic testing for cancer in children: Short-term psychological effect

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 11, 1996, Pages 1131-1138

  Codori, Ann Marie ^a   Petersen, Gloria M ^b   Boyd, Patricia A ^b   Brandt, Jason ^a   Giardiello, Francis M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CANCER SCREENING; CHILDHOOD CANCER; CLINICAL ARTICLE; DEPRESSION; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SCHOOL CHILD; SCORING SYSTEM; SELF REPORT;

EID: 0029904635     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170360021003     Document Type: Article

References (60)

1. Bassford TL, Hauck L. Human genome project and cancer: the ethical implications for clinical practice. Semin Oncol Nurs. 1993;9:134-138.
2. Bloch M, Adam S, Wiggins S, Huggins M, Hayden MR. Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk. Am J Med Genet. 1992;42:499-507.
3. Brandt J. Ethical considerations in genetic testing: an empirical study of presymptomatic diagnosis of Huntington's disease. In: Fulford KWM, ed. Medicine and Moral Reasoning. Cambridge, England: Cambridge University Press; 1994:41-59.
4. Codori AM, Hanson R, Brandt J. Self-selection in predictive testing for Huntington's disease. Am J Med Genet. 1994;54:167-173.
5. Codori AM, Brandt J. Psychological costs and benefits of predictive testing for Huntington's disease. Am J Med Genet. 1994;54:174-184.
6. Farrer LA. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am J Med Genet. 1986;24:305-311.
7. Folstein SE, Abbott MH, Chase GA, Jensen BA, Folstein MF. The association of affective disorder with Huntington's disease in a case series and in families. Psychol Med. 1983;13:537-542.
8. Huggins M, Bloch M, Kanani S, et al. Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington's disease. Am J Hum Genet. 1990;47:4-12.
9. Kessler S. Psychiatric implications of presymptomatic testing for Huntington's disease. Am J Orthopsychiatry. 1987;57:212-219.
10. Tibben A, Vegter-vanderVlis M, Skraastad MI, et al. DNA-testing for Huntington's disease in the Netherlands: a retrospective study on psychosocial effects. Am J Med Genet. 1992;44:94-99.
11. Li FP, Garber JE, Friend SH, Strong LC, Patenaude AF, Juengst ET, et al. Recommendations on predictive testing for germ line p53 mutations among cancer prone individuals. J Natl Cancer Inst. 1992;15:1156-1160.
12. Motulsky AG. Predictive genetic diagnosis. Am J Hum Genet. 1994;55:603-605.
13. Murray TH. Ethics, genetic prediction, and heart disease. Am J Cardiol. 1993; 72(suppl):80d-84d.
14. Offit K, Brown K. Quantitating familial cancer risk: a resource for clinical oncologists. J Clin Oncol. 1994;12:1724-1736.
15. Post N. Ethical implications of screening asymptomatic individuals. FASEB J. 1992;6:2813-2817.
16. Shore D, Berg K, Wynne D, Folstein MF. Legal and ethical issues in psychiatric genetic research. Am J Med Genet. 1993;48:17-21.
17. Wexler N. The Tiresias complex: Huntington's disease as a paradigm of testing for late-onset disorders. FASEB J. 1992;6:2820-2825.
18. Wertz DC, Fanos JH, Reilly PR. Genetic testing for children and adolescents: who decides? JAMA. 1994;272:875-881.
19. American Society of Human Genetics/American College of Medical Genetics Report. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57:1233-1241.
20. Sharpe NF. Presymptomatic Testing for Huntington disease: is there a duty to test those under the age of eighteen years? Am J Med Genet. 1993;46:250-253.
21. Bloch M, Hayden MR. Opinion: predictive testing for Huntington disease in childhood: challenges and implications. Am J Hum Genet. 1990;46:1-4.
22. Craufurd D, Donnai D, Kerzin-Storrar L, Osborn M. Testing of children for 'adult' genetic diseases. Lancet. 1990;335:1406.
23. Harper PS, Clarke A. Should we test children for 'adult' genetic diseases? Lancet. 1990;335:1205-1206.
24. Malkin D, Friend SH. Screening for cancer susceptibility in children. Curr Sci. 1994;6:46-51.
25. Scientific Advisory Board of the National Kidney Foundation. Gene testing in autosomal dominant adult polycystic kidney disease: results of a National Kidney Foundation workshop. Am J Kidney Dis. 1989;13:85-87.
26. Institute of Medicine, Committee on Assessing Genetic Risks. Assessing Genetic Risks: Implication for Health and Social Policy. Washington, DC: National Academy Press; 1993.
27. Went L. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. J Med Genet. 1990;27:34-38.
28. Groden J, Thliveris A, Samowitz W, H et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66:589-600.
29. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253:661-665.
30. Petersen GM, Francomano C, Kinzler K, Nakamura Y. Presymptomatic direct detection of adenomatous polyposis coli (APC) gene mutations in familial adenomatous polyposis. Hum Genet. 1993;91:307-311.
31. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med. 1993;329:1982-1987.
32. Bussey HJR. Familial Polyposis Coli: Family Studies, Histopathology, Differential Diagnosis, and Results of Treatment. Baltimore, Md: Johns Hopkins University Press; 1975.
33. Naylor EW, Gardner EJ. Penetrance and expressivity of the gene responsible for the Gardner syndrome. Clin Genet. 1977;11:381-393.
34. Bulow S. Familial polyposis coli. Dan Med Bull. 1987;34:1-15.
35. Herrera L. Familial Adenomatous Polyposis. New York, NY: Alan R Liss Inc; 1990.
36. Jagelman DG. Clinical management of familial adenomatous polyposis. Cancer Surv. 1989;8:159-167.
37. Neale K, Ritchie S, Thomson JPS. Screening of offspring of patients with familial adenomatous polyposis: the St. Mark's Hospital Polyposis Register experience. In: Herrera L, ed. Familial Adenomatous Polyposis. New York, NY: Alan R Liss Inc; 1990:61-66.
38. Bleday R, Wong WD. Recent advances in surgery for colon and rectal cancer. Curr Probl Cancer. 1993;17:7-55.
39. Winawer SJ, St John J, Bond J, et al. Screening of average-risk individuals for colorectal cancer. Bull World Health Organ. 1990;68:505-513.
40. Petersen GM. Knowledge of the adenomatous polyposis coli gene and its clinical application. Ann Med. 1994;26:205-208.
41. Kovacs M. Children's Depression Inventory. New York, NY: Multi-Health Systems Inc; 1992.
42. Reynolds WM. Reynolds Adolescent Depression Scale. Odessa, Florida: Psychological Assessment Resources; 1986.
43. Reynolds CR, Richmond BO. Revised Children's Manifest Anxiety Scale. Los Angeles, Calif: Western Psychological Services; 1985.
44. Achenbach TM. Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington: University of Vermont Department of Psychiatry; 1991.
45. Derogatis L. SCL-90R Manual-II. Towson, Md: Clinical Psychometric Research; 1983.
46. Beck AT. Beck Depression Inventory. Philadelphia, Penn: Harcourt Brace & Co; 1993.
47. Dent HR, Salkovskis PM. Clinical measures of depression, anxiety, and obsessionality in nonclinical populations. Behav Res Ther. 1986;24:689-691.
48. Lips HM, Ng M. Use of the Beck Depression Inventory with three non-clinical populations. Can J Behav Sci. 1985;18:62-74.
49. Kessler S. Invited essay on the psychological aspects of genetic counseling, V: preselection: a family coping strategy in huntington disease. Am J Med Genet. 1988;31:617-621.
50. Kessler S, Bloch M. Social system responses to Huntington disease. Fam Process. 1989;28:59-68.
51. Walsh PS, Metzger DA, Higuchi R. Chelex-100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991;10:506-513.
52. Joslyn G, Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell. 1991;66:601-613.
53. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991;253:665-669.
54. Miyoshi Y, Ando H, Nagase H, et al. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Nat Acad Sci USA. 1992;89: 4452-4456.
55. Lavigne JV, Burns WJ. Pediatric Psychology. New York, NY: Grune & Stratton Inc; 1981:7-36.
56. Moore BE, Fine BD. Psychoanalytic Terms and Concepts. New Haven, CT: American Psychoanalytic Association and Yale University Press; 1990:102-103.
57. Christ GH, Siegel K, Freund B, et al. Impact of parental terminal cancer on latency-age children. Am J Orthopsychiatry. 1993;63:417-425.
58. Baider L, Perez T, De-Nour AK. Gender and adjustment to chronic disease: a study of couples with colon cancer. Gen Hosp Psychiatry. 1989;11:1-8.
59. Bowlby J. Attachment and Loss. New York, NY: Basic Books Inc Publishers; 1982.
60. Armsden GC, Lewis FM. The child's adaptation to parental medical illness: theory and clinical implications. Patient Educ Counseling. 1993;22:153-165.